Acadian Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
152,271
-37,822
| -20% | -$261K | ﹤0.01% | 966 |
|
|
2025
Q1 | $1.01M | Buy |
+190,093
| New | +$1.01M | ﹤0.01% | 937 |
|
|
2024
Q4 | – | Sell |
-4,283
| Closed | -$87K | – | 1724 |
|
|
2024
Q3 | $87K | Sell |
4,283
-11,571
| -73% | -$235K | ﹤0.01% | 1635 |
|
|
2024
Q2 | $716K | Buy |
+15,854
| New | +$716K | ﹤0.01% | 1092 |
|
|
2023
Q1 | – | Sell |
-9,581
| Closed | -$31K | – | 1774 |
|
|
2022
Q4 | $31K | Buy |
9,581
+6,475
| +208% | +$21K | ﹤0.01% | 1651 |
|
|
2022
Q3 | $15K | Hold |
3,106
| – | – | ﹤0.01% | 1618 |
|
|
2022
Q2 | $23K | Buy |
+3,106
| New | +$23K | ﹤0.01% | 1601 |
|
|
2022
Q1 | – | Sell |
-6,134
| Closed | -$112K | – | 1661 |
|
|
2021
Q4 | $112K | Buy |
+6,134
| New | +$112K | ﹤0.01% | 1351 |
|